Hypoadiponectinemia, elevated iron and high-sensitivity C-reactive protein levels and their relation with prostate size in benign prostatic hyperplasia

被引:8
作者
Nandeesha, H. [1 ]
Eldhose, A. [1 ]
Dorairajan, L. N. [1 ]
Anandhi, B. [1 ]
机构
[1] Jawaharlal Inst Postgrad Med Educ & Res, Dept Biochem & Urol, Pondicherry, India
关键词
adiponectin; benign prostatic hyperplasia; C-reactive protein; iron; prostate-specific antigen; SERUM ADIPONECTIN; CANCER; TISSUE; RISK;
D O I
10.1111/and.12715
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
Elevated iron, high-sensitivity C-reactive protein (CRP) and hypoadiponectinemia are known to initiate tumour development. There is paucity of data regarding the above-mentioned parameters and their relation with prostate size in benign prostatic hyperplasia (BPH). The present study was designed to assess the levels of iron, hs-CRP and adiponectin levels and their association with prostate size in BPH patients. A total of 37 BPH cases and 36 controls were enrolled in the study. Iron, hs-CRP and adiponectin were estimated in both the groups. Iron and hs-CRP were significantly increased and adiponectin was significantly reduced in BPH cases when compared with controls. Iron (r=.397, p=.015), hs-CRP (r=.341, p=.039) and adiponectin (r=-.464, p=.004) were significantly associated with prostate size in BPH cases. Multivariate linear regression analysis showed that iron acts as predictor of prostate size in BPH (R-2 = 0.395, beta = 0.526, p=.001). We conclude that iron and hs-CRP are elevated and adiponectin is reduced in BPH cases and associated with prostate size.
引用
收藏
页数:3
相关论文
共 15 条
[11]   Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: A case control study [J].
Michalakis, Konstantinos ;
Williams, Catherine J. ;
Mitsiades, Nicholas ;
Blakeman, Jennifer ;
Balafouta-Tselenis, Sofia ;
Giannopoulos, Aris ;
Mantzoros, Christos S. .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (02) :308-313
[12]   Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer [J].
Ozmen, H ;
Erulas, FA ;
Karatas, F ;
Cukurovali, A ;
Yalcin, O .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2006, 44 (02) :175-179
[13]   Associations Between C-Reactive Protein and Benign Prostatic Hyperplasia/Lower Urinary Tract Symptom Outcomes in a Population-based Cohort [J].
Sauver, Jennifer L. St. ;
Sarma, Aruna V. ;
Jacobson, Debra J. ;
McGree, Michaela E. ;
Lieber, Michael M. ;
Girman, Cynthia J. ;
Nehra, Ajay ;
Jacobsen, Steven J. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 169 (11) :1281-1290
[14]   Serum Adiponectin, C-Peptide and Leptin and Risk of Symptomatic Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial [J].
Schenk, Jeannette M. ;
Kristal, Alan R. ;
Neuhouser, Marian L. ;
Tangen, Catherine M. ;
White, Emily ;
Lin, Daniel W. ;
Thompson, Ian M. .
PROSTATE, 2009, 69 (12) :1303-1311
[15]   Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults [J].
Wu, TJ ;
Sempos, CT ;
Freudenheim, JL ;
Muti, P ;
Smith, E .
ANNALS OF EPIDEMIOLOGY, 2004, 14 (03) :195-201